M&A Deal Summary |
|
---|---|
Date | 2022-06-29 |
Target | Integrated Surgical Solutions |
Sector | Business Services |
Buyer(s) | Evolent Health |
Sellers(s) | TPG |
Deal Type | Add-on Acquisition |
Deal Value | 375M USD |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Company |
---|---|
Founded | 2011 |
Sector | Information Technology |
Employees | 4,700 |
Revenue | 2.0B USD (2023) |
Evolent Health partners with major health systems to drive value-based care transformation. By providing clinical, analytical, and financial capabilities, Evolent helps physicians and systems achieve superior quality and cost results. Evolent Health was founded in 2011 and is based in Arlington, Virginia.
DEAL STATS | # |
---|---|
Overall | 5 of 6 |
Sector (Business Services) | 1 of 1 |
Type (Add-on Acquisition) | 5 of 5 |
State (Georgia) | 1 of 1 |
Country (United States) | 5 of 6 |
Year (2022) | 1 of 2 |
Size (of disclosed) | 1 of 4 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2021-08-04 |
Vital Decisions
Edison, New Jersey, United States Vital Decisions provides proprietary counseling services to advanced illness patients. Vital Decisions' Living Well Program addresses inadequate communication and shared decision-making between patient, provider, and family during a serious illness in order to improve the value and quality of healthcare delivered. Vital Decisions was founded in 2006 and is based in Edison, New Jersey. |
Buy | $130M |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-11-17 |
Magellan Specialty Health
United States Magellan Specialty Health is a specialty benefit management organization that offers industry-leading utilization management solutions to health plans, including radiology management, musculoskeletal management, physical medicine management, and genetic testing solutions. Magellan Specialty Health is based in United States. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1992 |
PE ASSETS | 137.0B USD |
Size | Mega |
Type | Sector Agnostic |
TPG Capital is a global, mega-sized private investment firm that manages a family of funds focused on private equity, real estate, venture capital, public equity and debt investing. TPG invests in opportunities across a broad range of industries and geographies. TPG generally seeks to invest in established businesses that can benefit from the Firm's operational experience and connections. Industries of interest include consumer, retail, healthcare, industrials, digital media, natural resources, energy, real estate, technology, and software. TPG was formerly known as Texas Pacific Group and was originally established in 1992 by David Bonderman, James Coulter and William Price. The Firm is based in Forth Worth, Texas with additional offices in Europe, Asia, and Australia.
DEAL STATS | # |
---|---|
Overall | 239 of 248 |
Sector (Business Services) | 8 of 9 |
Type (Add-on Acquisition) | 85 of 89 |
State (Georgia) | 5 of 6 |
Country (United States) | 176 of 183 |
Year (2022) | 3 of 5 |
Size (of disclosed) | 54 of 71 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-05-25 |
Covetrus
Portland, Maine, United States Covetrus is a provider of technology-enabled healthcare services for companion and equine veterinary practitioners. The company partners with veterinarians to create insight into gaps in patient care and offer professionalized pro-active prescription management to drive client engagement and improve compliance. Covetrus was formed in 2010 and is based in Portland, Maine. |
Buy | $4.0B |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-06-30 |
Doc Generici
Milan, Italy Doc Generici provides drugs for the treatment of common medical conditions with a broad product portfolio and a strong presence in areas including cardiovascular, gastrointestinal/metabolism and neurological treatments. Doc Generici operates an asset-light model and benefits from a consolidated network of suppliers. Doc Generici was founded in 1996 and is based in Milan, Italy. |
Buy | - |